PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

Size: px
Start display at page:

Download "PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK"

Transcription

1 PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK Ian Brownwood, HCQI Project, OECD HCQI Expert Group Meeting 21 and 22 may 2015

2 R&D Agenda for 2014 Primary Care Indicators Avoidable Hospital Admission Indicators led by the United Kingdom Composite Indicator for Avoidable Hospital Admissions led by Canada Standardised Definition and Calculation of Lower Extremity Amputation Rates led by Italy Acute Care Indicators Hip Fracture Surgery within 48 Hours after Hospital Admission led by the Netherlands and Germany Mental Health Indicators International Suicide Indicators led by Denmark Excess Mortality from Serious Mental Illness led by the United Kingdom Cross-Cutting Themes Use of Health Care Quality Indicators in National and Regional Reports led by the Netherlands. In addition to this work, the HCQI secretariat has carried out ongoing development and refinement of other indicators with the HCQI set, including: Prescribing in primary care Patient safety.

3 HCQI Data Collection Significant changes resulted from agreed outcomes of HCQI Expert Group meeting in Nov 2015 Changes reflected in guidelines and technical specification for the HCQI Data Collection Changes reviewed by lead countries Reflection on the R&D data from the HCQI Data Collection

4 PRIMARY CARE INDICATORS Ian Brownwood, HCQI Project, OECD HCQI Expert Group Meeting May 2015

5 1. Avoidable Hospital Admissions Changes to indicator specifications: Multiple data records for the period of patient care from formal admission to formal discharge Treatment of transfers to both maximise identification and avoid double counting Exclude cases with obstetric diagnosis code in any diagnosis field where MDC assignment not possible

6 Changes to Indicator Specifications Compliance Multiple Records About 50% of countries have multiple records 100% of countries report using all records Exclusion of Transfers About 75% of countries excluded transfers Only about 50% of these countries were confident they only excluded double counting cases Assessment of impact of transfers warranted

7 Changes to Indicator Specifications Exclusion of Obstetric Cases About 70% of countries used the code list, with most of the countries confirming they used all diagnosis fields Impact Comparison of initial and updated 2011 rates Some countries have revised rates, notably Sweden and Canada (e.g. excludes only acute hospital transfers) Added value to robustness of data

8 1. Avoidable Hospital Admissions Use of Secondary Diagnosis for Diabetes: diabetes-related complication in PDx along with a diagnosis of diabetes in SDx list of agreed complications not available for HCQI data collection existing coding conventions (i.e. asterisk and dagger codes) HCQI data collection assessed alternative coding practices

9 Use of Secondary Diagnosis for Diabetes Diabetes admissions identified using SDx as a proportion admissions identified using PDx, % 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% Note: Luxembourg data excluded awaiting further validation

10 Use of Secondary Diagnosis for Diabetes Rate for some countries (e.g. Korea) is likely to be understated compared with other countries, given current coding practices

11 1. Avoidable Hospital Admissions Further R & D on Diabetes Indicator existing code pairs do not reflect all risk-outcome relationships for diabetes modest approach to exploring use of SDx in HCQI Data Collection was modest HCQI Bureau meeting (Feb 2015) members (Canada, Italy, UK, US) showed interest in further consideration of SDx use

12 Further R & D on Diabetes Indicator Expert teleconference in March 2015 involving Bureau members and invited clinical and coding experts in diabetes: Professor Massimo Massi Benedetti, Co-coordinator of BIRO and EUBIROD projects, Italy Naomi Holman, Head of Health Intelligence for Diabetes, National Cardiovascular Intelligence Network, Public Health England, United Kingdom Bob Young, Consultant Diabetologist and Clinical Lead for the National Diabetes Audit and the National Diabetes Information Service, United Kingdom Professor Patrick Romano, UC David School of Medicine, United States Yana Gurevich, Manager, Health Indicators and Client Support, Canadian Institute for Health Information (CIHI), Canada Alana Lane, Classifications Specialist, CIHI, Canada Janet Manuel, Classifications Specialist, CIHI, Canada

13 Further R & D on Diabetes Indicator Background paper: Intent of the indicator Existing coding conventions Implications for composite indicators Use of secondary diabetes codes Broad agreement on further R&D work

14 Further R & D on Diabetes Explores the use of secondary diagnosis fields based on existing code sets (e.g. Canada, UK, Australia) Caters for variations in coding practices by allowing use of both PDx and SDx fields Seeks to better understand coding practices of countries

15 Use of Secondary Diagnosis HCQI Data Collection: Proposed use of ICD 10 Chapter IX (Diseases of the Circulatory System) SDx Diabetes CHF and Hypertension Use of SDx has flow-on implications for planned composite indicator. Broader issues of dealing with comorbidity

16 CHF Avoidable Hospital Admissions CHF: Proportion of Total Admissions with a Diabetes Secondary Diagnosis, % 50% 40% 30% 20% 10% 0% Finland Portugal Netherlands Slovenia Spain Canada Israel

17 Hypertension Avoidable Admissions Hypertension: Proportion of Total Admissions with a Diabetes Secondary Diagnosis, % 30% 25% 20% 15% 10% 5% 0% Slovenia Netherlands Finland Portugal Canada Israel Spain

18 2. Composite Indicator Collect data on all 5 indicators with a view to publication of composite indicator in Health at a Glance Collection of supplementary data: in-hospital mortality coding depth, coding standards missing data

19 International Variation Lowest Rate (per 100,000) Highest Rate (per 100,000) Variation (2013) Variation (2011) Diabetes fold 8-fold Asthma fold 14-fold COPD fold 16-fold Asthma + COPD fold 8-fold CHF fold 10-fold Hypertension fold 374-fold CHF + Hypertension fold 14-fold Overall Composite fold 4-fold

20 Mortality data Explore impact of excluding admissions where death occurred, given these admissions are likely not to be avoidable Over a third of countries did not provide data Downward impact on rates: Asthma (- 0.6%) Hypertension (- 1.6%) Diabetes (- 2.5%) COPD (- 4.1%) CHF (- 8.9%)

21 Impact of excluding mortality Difference between avoidable admission rate with and without inclusion of in-hospital deaths 18.0% 16.0% Average 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% Asthma Hypertension Diabetes COPD CHF

22 Impact of excluding mortality CHF hospital admission in adults aged 15 and over, 2013 (or nearest year) per population 600 Without excluding deaths Excluding deaths

23 Impact of excluding mortality International Variation With and Without Inclusion of In-hospital Deaths. Variation including deaths Variation excluding deaths Asthma 8.6-fold 8.6-fold COPD 5.5-fold 5.6-fold CHF 7.4-fold 7.6-fold Hypertension 46.3-fold 48.0-fold Diabetes 7.1-fold 7.1-fold

24 Coding Depth Number of secondary diagnosis fields in country datasets. Question referred to dataset capacity rather than actual use Third of countries = unlimited Some of these countries provided further insights (e.g. Denmark = 19, Finland = 3) Data revealed significant variation Confront with data on SDx from Patient Safety

25 Coding Depth Country No SDx Fields Canada 31 Czech Republic 4 Ireland 29 Italy 5 Korea 19 Luxembourg 3 Mexico 0 Netherlands 10 Norway 20 New Zealand 99 Poland 5 Slovenia 19 Spain 14 Switzerland 50

26 Coding Standards Coding variations specific coding standards or practices exist for conditions covered by the indicators About 70% of counties report they do not have standards Seven countries (Canada, Chile, Ireland, Mexico, New Zealand, Slovenia and Spain) provided information on their standards. Degree of convergence - use or adaption of Australian coding standards in 3 countries

27 Missing Indicators Only 4 countries reported not being able to provided data on all avoidable hospital admission indicators, with coding capacity (e.g. lack of procedure codes) issues being highlighted

28 Recommendations Further R&D Further assess impact of excluding transfers on avoidable admission rates Further explore use of secondary diagnosis in calculation of diabetes avoidable admissions include consideration of coding depth and coding standards and practices Assess overall capacity to report in-hospital mortality.

29 Recommendations Publication in Health at a Glance 2015 publish both overall composite and subcomposite charts for avoidable admission indicators. publish avoidable hospital indicator rates including in-hospital deaths

30 PROGRESS REPORTS ON HCQI DATA COLLECTION : AVOIDABLE HOSPITAL ADMISSIONS Ian Brownwood, HCQI Project, OECD HCQI Expert Group Meeting May 2015

31 Avoidable Hospital Admissions Update - since preparation of agenda paper: Iceland, UK, US provided data Italy, Mexico updated data on diabetes Data reflected in following charts Data source - Colombia reported data is not nationally representative subject to further validation Compliance - 13 countries did not exclude transfers and/or were not able to exclude only those transfers that would have resulted in double counting

32 Asthma Avoidable Admissions Asthma hospital admission in adults aged 15 and over, 2013 (or nearest year) per population

33 Asthma Avoidable Admissions Indicator was published in Health at a Glance 2013 International variation = 11-fold (2011 = 14-fold) Rate in most countries decreased over past five years between 2008 and 2013 (or nearest years), except for Denmark (3.9% increase), Netherland (13% increase), Slovenia (6.4% increase) and Sweden (15.3% increase) Observed annual pattern or trend over previous five years is relatively consistent with these changes, except for Demark where a decreasing trend has been evident Only Mexico did not exclude all cases with a cystic fibrosis and anomalies of the respiratory system diagnosis code in any field Data received from 32 countries. Data for 3 countries presented using data from previous data collections (Australia, Germany, Hungary). Data will be updated if suitable data is received prior to publication deadline for Health at a Glance 2015 It is planned that data from all countries will be published, except for Colombia (subject to further validation)

34 COPD Avoidable Admissions COPD hospital admission in adults aged 15 and over, 2013 (or nearest year) per population

35 COPD Avoidable Admissions Indicator was published in Health at a Glance 2013 International variation = 17-fold (2011 = 16-fold) Rate in most countries decreased over past five years between 2008 and 2013 (or nearest years), except for Canada (20.1%), France (+41.9%), Netherlands (+0.1%), Slovak Republic (+39.7%), Sweden (+17.4%) and Switzerland (+16.3%) Observed annual pattern or trend over previous five years is relatively consistent with these changes, except for Slovak Republic and Switzerland where a decreasing trend has been evident and Sweden where the rate has kept relatively steady Data received from 32 countries. Data for 3 countries is from previous data collections (Australia, Germany, Hungary). Data will be updated if suitable data is received prior to publication deadline for Health at a Glance 2015 It is planned that data from all countries will be published, except for Colombia (subject to further validation).

36 CHF Avoidable Admissions CHF hospital admission in adults aged 15 and over, 2013 (or nearest year) per population

37 CHF Avoidable Admissions Indicator was not published in Health at a Glance 2013 International variation = 7-fold (2011 = 10-fold) Rate in most countries has decreased over the past five years between 2008 and 2013 (or nearest years), except for Canada (13.5%), Czech Republic (14.2%), Portugal (2.3%), Slovak Republic (5.6%), Slovenia (823.4%), Spain(9.2%), Sweden (13.9%) and Switzerland (0.6%). Significant increase in rate for Slovenia in 2013 is most likely attributable to a change in data reporting methodology. Observed annual pattern or trend over previous five years is relatively consistent with changes between 2008 and 2013, except for Canada and Portugal where a decreasing trend has been evident and Sweden where the rate has kept relatively steady. Rates for Canada and Sweden are consistent with a change in data reporting resulting from changes in the HCQI data specifications for (e.g. treatment of transfers). Only Mexico, Slovak Republic and Colombia did not exclude all cases with cardiac procedure codes. While Belgium, Czech Republic and Switzerland excluded all cases with cardiac procedure codes, they were not able to effectively map specified ICD-9-CM codes to the procedure classification in their country. Data received from 29 countries. Data for 4 countries is presented using earlier data from previous data collections (Australia, Germany, Hungary,, Latvia). Data will be updated if suitable data is received prior to the publication deadline for Health at a Glance It is planned that data from all countries will be published, except for Colombia (subject to further validation).

38 Hypertension Avoidable Admissions Hypertension hospital admission in adults aged 15 and over, 2013 (or nearest year) per population

39 Hypertension Avoidable Admissions Indicator was not published in Health at a Glance 2013 International variation = 46-fold (2011 = 374-fold). Rate in most countries decreased over past five years between 2008 and 2013 (or nearest years), except for Israel (3.4%), Netherlands (7.8%), Portugal (15.6%), Slovak Republic (0.1%) and Slovenia (848.9%). Significant increase in rate for Slovenia in 2013 most likely attributable to a change in data reporting methodology. Observed annual pattern or trend over previous five years is relatively consistent with the changes between 2008 and 2013, except for Slovak Republic and Israel where a decreasing trend has been evident, Mexico where an increasing trend has been evident and Czech Republic where the rate has kept relatively steady. Only Mexico, Slovak Republic and Colombia did not exclude all cases with cardiac procedure codes. While Belgium, Czech Republic and Switzerland excluded all cases with cardiac procedure codes, they were not able to effectively map the specified ICD-9-CM codes to the procedure classification in their country. Data received from 29 countries. Data for 4 countries has been presented using data from previous data collections (Australia, Germany, Hungary, Latvia). This data will be updated if suitable data is received prior to the publication deadline for Health at a Glance It is planned that data from all countries will be published, except for Colombia (subject to further validation).

40 Diabetes Avoidable Admissions Diabetes hospital admission in adults aged 15 and over, 2013 (or nearest year) per population

41 Diabetes Avoidable Admissions Indicator was published in Health at a Glance 2013 Combines the uncontrolled diabetes without complication, diabetes short-term complications and diabetes long-term complications indicators. International variation = 8-fold (2011 = 8-fold) Rate in most countries has decreased over past five years between 2008 and 2013 (or nearest years), except for France (717.4%), Netherlands (13.6%), New Zealand (17%), Poland (18.0%) Singapore (63.9%) and Slovenia (50.1%). Observed annual pattern or trend over the previous five years is relatively consistent with the changes between 2008 and 2013, except for France where a decreasing trend has been evident and Slovenia, Spain and Switzerland where the rate has kept relatively steady. Over 40% of countries using ICD 10 or equivalent classification reported not being able to effectively distinguish between uncontrolled and controlled diabetes. 5 countries reported use of ICD-9-CM. Data was received from 28 countries by the 15 April 2015 for this indicator. Data for six countries has been presented using earlier data from previous data collections (Australia, Germany, Hungary, Iceland, United Kingdom and United States. This data will be updated if suitable data is received prior to the publication deadline for Health at a Glance It is planned that data from all countries will be published, except for Italy, Mexico and Colombia (subject to further validation).

42 HEALTH AT A GLANCE 2015 AVOIDABLE HOSPITAL ADMISSIONS

43 Recommendations Avoidable Hospital Admissions: Overall composite indicator (including Diabetes, Asthma, COPD, CHF and Hypertension) Respirator sub-composite (Asthma and COPD) Cardiovascular sub-composite (CHF and Hypertension) Diabetes Indicators Diabetes hospital admission Lower extremity amputation indicators Prescribing in primary care (diabetics)?

44 Overall Composite Avoidable Hospital Admissions for Selected Chronic Conditions, 2013 (or nearest year) Age-sex standardised rates per 100, Asthma and COPD CHF and Hypertension Diabetes

45 Composite for Respiratory Conditions Avoidable Hospital Admissions for Selected Respiratory Conditions, 2013 (or nearest year) Age-sex standardised rates per 100, Asthma COPD

46 Composite for Cardiovascular Conditions Avoidable Hospital Admissions for Selected Cardiovascular Conditions, 2013 (or nearest year) Age-sex standardised rates per 100, CHF Hypertension

47 Diabetes Diabetes Avoidable Hospital Admissions Conditions, 2013 (or nearest year) Age-sex standardised rates per 100,

48 HEALTH AT A GLANCE 2015 DIABETES LOWER EXTREMITY MAJOR AMPUTATION

49 Diabetes Lower Extremity Amputation Total Population per population Admission-based diabetes lower extremity amputation, 2013 (or nearest year)

50 Diabetes Lower Extremity Amputation Estimated Diabetes Population Diabetes Major Lower Extremity Amputations Rate (Estimated Diabetic Population), 2013 (or nearest year)

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with

More information

Methodological Issues

Methodological Issues Methodological Issues Presentation by Ian Brownwood for the meeting of Health Promotion, Prevention and Primary Care Subgroup 22 October, 2009, Paris The Indicators Asthma* Chronic Obstructive Pulmonary

More information

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes

More information

Indicators of suicide among people with serious mental illness

Indicators of suicide among people with serious mental illness Indicators of suicide among people with serious mental illness OECD/Denmark Mette Jørgensen, Søren Paaske Johnsen, Poul Erik Hansen, Katrine Grau, Jette Bauer and Jan Mainz Friday 14th November 2014 Agenda

More information

Allied Health: Sustainable Integrated Health Care for all Australians

Allied Health: Sustainable Integrated Health Care for all Australians Allied Health: Sustainable Integrated Health Care for all Australians Catherine Turnbull Chief Allied and Scientific Health Advisor SA Health Presentation to Indigenous Allied Health Australia Conference,

More information

Analysis of the impact of AHRQ exclusions on the variation in Patient Safety Indicator (PSI) values

Analysis of the impact of AHRQ exclusions on the variation in Patient Safety Indicator (PSI) values Analysis of the impact of AHRQ exclusions on the variation in Patient Safety Indicator (PSI) values by Vladimir Stevanovic Patient Safety Subgroup meeting Paris, 26 May 2011 Background HCQI Expert Group

More information

CARDIOVASCULAR DISEASE AND DIABETES:

CARDIOVASCULAR DISEASE AND DIABETES: CARDIOVASCULAR DISEASE AND DIABETES: HOW OECD HEALTH SYSTEMS DELIVER BETTER OUTCOMES? Progress report 7 th November 2013 Outline Overview of the project Preliminary results Descriptive Analytical Next

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the

More information

The OECD Health Care Quality Indicators Project

The OECD Health Care Quality Indicators Project The OECD Health Care Quality Indicators Project Ed Kelley, Ph.D. Head, OECD Health Care Quality Indicators Project Health Systems Working Party Luxembourg - April 26, 2005 1 Broad aims of the OECD s HCQI

More information

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

Appendix F: Test-Curriculum Matching Analysis

Appendix F: Test-Curriculum Matching Analysis Appendix F: Test-Curriculum Matching Analysis TIMSS went to great lengths to ensure that comparisons of student achievement across countries would be as fair and equitable as possible. The TIMSS 2015 Assessment

More information

Smokefree Policies in Europe: Are we there yet?

Smokefree Policies in Europe: Are we there yet? Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially

More information

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world. 1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health

More information

World Connections Committee (WCC) Report

World Connections Committee (WCC) Report World Connections Committee (WCC) Report 06 Co-Dependents Anonymous Service Conference Countries Where CoDA Exists This report reflects the World Connections Committee (WCC) support of the growth and development

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

DENMARK. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018 DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000

More information

GERMANY. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018 GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000

More information

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479 Appendix F The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479 TIMSS went to great lengths to ensure that comparisons of student achievement across

More information

Louisville '19 Attachment #69

Louisville '19 Attachment #69 Telephone Meeting Approved and why I propose Using zoom to fulfill both Phone and Virtual video meeting Formats. The first established phone meeting Sanctioned by Gamblers Anonymous (listed on Trustee

More information

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care Policy Brief Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care June 2015 Directorate for Employment, Labour and Social Affairs Over the last few decades, mortality from

More information

Johns Hopkins individualized Health Initiative

Johns Hopkins individualized Health Initiative Johns Hopkins individualized Health Initiative Hopkins inhealth Scott L. Zeger Professor of Biostatistics Vice Provost for Research Chair, Johns Hopkins Individualized Health Steering Committee May 16,

More information

What is the extent of gender bias in bioinformatics?

What is the extent of gender bias in bioinformatics? What is the extent of gender bias in bioinformatics? Keith R. Bradnam krbradnam@ucdavis.edu, @kbradnam Genome Center, University of California, Davis Introduction As a male bioinformatician, I was curious

More information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Department of Biological Standardisation OMCL Network & Healthcare (DBO) Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE

More information

Access to treatment and disease burden

Access to treatment and disease burden Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor

More information

Urgent Medical Device Correction

Urgent Medical Device Correction Urgent Medical Device Correction Contact TM Detach Infusion Sets: Needle May Fracture From the Connect/Disconnect Location August 10, 2015 Dear Valued Customer: Unomedical a/s, a ConvaTec Company has initiated

More information

Differences make a Difference

Differences make a Difference Differences make a Difference The European Mens Health Forum: Overview European Mens Health: An oxymoron? Mens use of services: Self-care & navigation Good practice: Wot does work? A Storm is coming: Man

More information

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has

More information

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Collaboration on Dementia. Luxembourg, 13 December 2006 European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,

More information

BioPlex 2200 Infectious Disease Panels

BioPlex 2200 Infectious Disease Panels BioPlex 2200 System BioPlex 2200 Infectious Disease Panels An Expanding Multiplexed Assay Menu Lyme HIV Ag-Ab MMV IgM Syphilis Total & RPR MMRV EBV HSV-1 & HSV-2 EBV IgM ToRC IgM ToRC Leading the way with

More information

Global EHS Resource Center

Global EHS Resource Center Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research

More information

The Risk of Alcohol in Europe. Bridging the Gap June 2004

The Risk of Alcohol in Europe. Bridging the Gap June 2004 The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other

More information

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11 Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11 12/15/11 Aruba All 20% off 08/24/11 12/15/11 Australia

More information

Main developments in past 24 hours

Main developments in past 24 hours ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance

More information

CND UNGASS FOLLOW UP

CND UNGASS FOLLOW UP CND UNGASS FOLLOW UP INCB follow-up activities on Chapter 2. Operational recommendations on ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes,

More information

3.1 PHASE 2 OF THE GLOBAL PROJECT

3.1 PHASE 2 OF THE GLOBAL PROJECT RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided

More information

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division The costs of poor mental health Estimates of Direct and Indirect Costs of Mental Illness 1 All

More information

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk

More information

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini, S. Martire Istituto Superiore

More information

Table 6.1 Summary information for colorectal cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland, 6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

Where do EU Contries set the limit for low risk drinking.

Where do EU Contries set the limit for low risk drinking. Where do EU Contries set the limit for low risk drinking. Results from the EU RARHA survey E. Scafato,L. Galluzzo, S. Ghirini, C. Gandin Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)

More information

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT UNITED NATIONS A General Assembly Distr. LIMITED A/HRC/11/L.16 16 June 2009 Original: ENGLISH HUMAN RIGHTS COUNCIL Eleventh session Agenda item 3 PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL,

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

The Urgency of the Situation: The Cost of Childhood Obesity for Society

The Urgency of the Situation: The Cost of Childhood Obesity for Society The Urgency of the Situation: The Cost of Childhood Obesity for Society Lisa M. Powell, PhD Distinguished Professor and Director Health Policy and Administration School of Public Health University of Illinois

More information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria

More information

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c VARIANT II TURBO Link Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing VARIANT II TURBO Link Efficient streamlined process Powerful

More information

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines Request for Letters of Intent International Development of H5N1 Influenza Vaccines The World Health Organization (WHO) intends to provide funding to developing (1) country vaccine manufacturers to develop

More information

11 Melanoma of the skin

11 Melanoma of the skin 11 Melanoma of the skin 11.1 Summary Melanoma of the skin is the ninth most common cancer in Ireland, accounting for 2.4 of all malignant neoplasia in men and 4.2 in women, if non-melanoma skin cancers

More information

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective? FOURIER STUDY Did the study achieve its main objective? 2 15% 1 5% 9.8% YES FOURIER compared Repatha with placebo in patients who were taking a statin and had hardening or narrowing of the arteries and

More information

Q1 What age are you?

Q1 What age are you? Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%

More information

Weekly Influenza Surveillance Report. Week 11

Weekly Influenza Surveillance Report. Week 11 Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices

More information

All about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April

All about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April All about interrai Len Gray Coordinator, interrai Network of Excellence in Acute Care April 2014 The interrai research collaborative Australia Belgium Canada Chile China Czech Republic Denmark Estonia

More information

The Test-Curriculum Matching Analysis: Science

The Test-Curriculum Matching Analysis: Science Appendix C The Test-Curriculum Matching Analysis: Science TIMSS went to great lengths to ensure that comparisons of student achievement across countries would be as fair and equitable as possible. The

More information

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing Bio-Rad Laboratories BioPlex 2200 System BioPlex 2200 MMRV IgG Kit The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing Bio-Rad

More information

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE) Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE) John Laffey, Giacomo Bellani, Tai Pham, Eddy Fan, Antonio Pesenti on behalf of the LUNG SAFE Investigators

More information

Type 1 Diabetes Australian Research Impact Analysis

Type 1 Diabetes Australian Research Impact Analysis Type 1 Diabetes Australian Research Impact Analysis Executive Overview Summary Type 1 diabetes research in Australia Australia is making a significant contribution to the quantity and quality of the global

More information

Suicide in Wales. Professor Keith Lloyd School of Medicine.

Suicide in Wales. Professor Keith Lloyd School of Medicine. Suicide in Wales Professor Keith Lloyd School of Medicine www.swansea.ac.uk Definitions Suicide intentionally killing oneself Self harm intentional selfpoisoning or selfinjury, irrespective of the nature

More information

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

OECD Family database  OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs SF.5: Childlessness Definitions and methodology The postponement of parenthood over the last decades, which can be gleaned from the declining percentage of childless women at different points over the

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit EFSA s Concise European food consumption database Davide Arcella Data Collection and Exposure Unit 1 The EFSA raison d être Risk assessment authority created in 2002 as part of a comprehensive program

More information

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers WELLNESS COACHING Wellness & Personal Fitness Solution Providers Introducing Ourselves... We are Personal Wellness Coaches 2 We help people look and feel better by: - Educating on proper nutrition (80%)

More information

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,

More information

Rheumatoid Arthritis Disease Burden and Access to Treatment

Rheumatoid Arthritis Disease Burden and Access to Treatment Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers

More information

Case study examining the impact of German reunification on life expectancy

Case study examining the impact of German reunification on life expectancy Supplementary Materials 2 Case study examining the impact of German reunification on life expectancy Table A1 summarises our case study. This is a simplified analysis for illustration only and does not

More information

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c VARIANT II TURBO Link System Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing VARIANT II TURBO Link System Efficient streamlined

More information

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network The Fragility Fracture Network of the Bone and Joint Decade Mission: To promote globally

More information

Available Hepatitis Information: how can this be used to convince decision makers and potential funders

Available Hepatitis Information: how can this be used to convince decision makers and potential funders Available Hepatitis Information: how can this be used to convince decision makers and potential funders H. Razavi June 6, 2015 Viral Hepatitis Prevention Board Meeting, London, UK 56 June 2015 It s not

More information

Cross Border Genetic Testing for Rare Diseases

Cross Border Genetic Testing for Rare Diseases Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B J.C. Lang, D.M. Abrams, and H. De Sterck A Additional Tables and Figures Table

More information

Cardiac Assessment Controls

Cardiac Assessment Controls Bio-Rad Laboratories CARDIAC ASSESSMENT CONTROLS Cardiac Assessment Controls Value Assigned for Clinical Laboratory and Point of Care Test Systems Solving the Challenges of Troponin I Testing for the Central

More information

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke «L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of

More information

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases 15. KIDNEY CANCER 15.1. SUMMARY Kidney cancer was the twelfth most common cancer in Ireland, accounting for 1.8% of all malignant neoplasms, excluding non-melanoma skin cancer, in women and 2.8% in men

More information

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014 Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role

More information

Engagement in language assessment / Regions of Europe

Engagement in language assessment / Regions of Europe Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears

More information

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 Emerging Risks Mapping of Activities in Member States 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 BACKGROUND 67 th Advisory Forum Meeting, Utrecht, The Netherlands, 6 February

More information

Alcohol Prevention Day

Alcohol Prevention Day Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in

More information

OECD S HEALTH AT A GLANCE 2015 WHAT INSIGHTS FOR THE UK? Mark Pearson, Deputy Director Directorate for Employment, Labour and Social Affairs

OECD S HEALTH AT A GLANCE 2015 WHAT INSIGHTS FOR THE UK? Mark Pearson, Deputy Director Directorate for Employment, Labour and Social Affairs OECD S HEALTH AT A GLANCE 2015 WHAT INSIGHTS FOR THE UK? Mark Pearson, Deputy Director Directorate for Employment, Labour and Social Affairs Health at a Glance 2015 How does the UK perform? A leader in

More information

Transmission, processing and publication of HBS 2015 data

Transmission, processing and publication of HBS 2015 data EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-4: Income and living conditions; Quality of life Doc. LC-ILC/194/17/EN estat.f.4 (2017) WORKING GROUP ON INCOME AND LIVING CONDITIONS

More information

ICD-10-CM Foundation Training

ICD-10-CM Foundation Training ICD-10-CM Foundation Training 1 Objectives What is ICD-10? Benefits of ICD-10 ICD-10 Impacts Important Facts about ICD-10 Where to Get More Information Codebook Structure Conventions Overview Code Structure

More information

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist Undetectable = Untransmittable Mariah Wilberg Communications Specialist Undetectable=Untransmittable PLWH who get and stay undetectable have effectively no risk of transmitting HIV to their sex partners

More information

Brunswik-Symmetry: A key concept for successful assessment tin education and elsewhere. Werner W. Wittmann University of Mannheim, Germany

Brunswik-Symmetry: A key concept for successful assessment tin education and elsewhere. Werner W. Wittmann University of Mannheim, Germany Brunswik-Symmetry: A key concept for successful assessment tin education and elsewhere Werner W. Wittmann University of Mannheim, Germany Session III: Diagnostics in Everyday Cognition Chair: Patrick Kyllonen

More information

GLP in the European Union Ecolabel detergents, GLP and accreditation

GLP in the European Union Ecolabel detergents, GLP and accreditation GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European

More information

This document is a preview generated by EVS

This document is a preview generated by EVS TECHNICAL REPORT RAPPORT TECHNIQUE TECHNISCHER BERICHT CEN/TR 17223 March 2018 ICS 03.100.70; 11.040.01 English version Guidance on the relationship between EN ISO 13485: 2016 (Medical devices - Quality

More information

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank Country CAPEXIL Description HS Code Value 2010-2011 Quantity 2010-2011

More information

Table 9.1 Summary information for stomach cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland, 9 Stomach cancer 9.1 Summary Stomach cancer ranks seventh in terms of the most common cancers in Ireland, accounting for 4.1% of all malignant neoplasia in men and 2.8% in women, when non-melanoma skin

More information

Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati Colorectal cancer New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information